Your browser doesn't support javascript.
loading
Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis.
Kehr, Sarah; Berg, Philipp; Müller, Susanne; Fiedler, Sarah A; Meyer, Britta; Ruppert-Seipp, Gabriele; Witzenhausen, Cornelia; Wolf, Marc E; Henkes, Hans H; Oberle, Doris; Keller-Stanislawski, Brigitte; Funk, Markus B.
Afiliación
  • Kehr S; Paul-Ehrlich-Institut (Federal Institute for Vaccines and Biomedicines), Division Safety of Medicinal Products and Medical Devices, Langen, Germany.
  • Berg P; Paul-Ehrlich-Institut (Federal Institute for Vaccines and Biomedicines), Division Safety of Medicinal Products and Medical Devices, Langen, Germany.
  • Müller S; Paul-Ehrlich-Institut (Federal Institute for Vaccines and Biomedicines), Division Safety of Medicinal Products and Medical Devices, Langen, Germany.
  • Fiedler SA; Paul-Ehrlich-Institut (Federal Institute for Vaccines and Biomedicines), Division Safety of Medicinal Products and Medical Devices, Langen, Germany.
  • Meyer B; Paul-Ehrlich-Institut (Federal Institute for Vaccines and Biomedicines), Division Safety of Medicinal Products and Medical Devices, Langen, Germany.
  • Ruppert-Seipp G; Paul-Ehrlich-Institut (Federal Institute for Vaccines and Biomedicines), Division Safety of Medicinal Products and Medical Devices, Langen, Germany.
  • Witzenhausen C; Paul-Ehrlich-Institut (Federal Institute for Vaccines and Biomedicines), Division Safety of Medicinal Products and Medical Devices, Langen, Germany.
  • Wolf ME; Department of Neurology, Klinikum Stuttgart, Stuttgart, Germany.
  • Henkes HH; Department of Neuroradiology Klinikum Stuttgart, Stuttgart, Germany.
  • Oberle D; Paul-Ehrlich-Institut (Federal Institute for Vaccines and Biomedicines), Division Safety of Medicinal Products and Medical Devices, Langen, Germany.
  • Keller-Stanislawski B; Paul-Ehrlich-Institut (Federal Institute for Vaccines and Biomedicines), Division Safety of Medicinal Products and Medical Devices, Langen, Germany.
  • Funk MB; Paul-Ehrlich-Institut (Federal Institute for Vaccines and Biomedicines), Division Safety of Medicinal Products and Medical Devices, Langen, Germany. markus.funk@pei.de.
NPJ Vaccines ; 7(1): 76, 2022 Jul 05.
Article en En | MEDLINE | ID: mdl-35790739

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: NPJ Vaccines Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: NPJ Vaccines Año: 2022 Tipo del documento: Article País de afiliación: Alemania